In brief: Nationwide Medical ‘unlocks potential,’ Dynamic Infusion makes buy, Insulet awarded damages 

CALABASAS, Calif. – Nationwide Medical, a sleep and respiratory provider that operates in 49 states and serves more than 100,000 patients, has formed a growth partnership with Heritage Group, a health care-focused private equity firm.  

“Today marks an exciting milestone for Nationwide Medical,” said CEO David Siegel. “We have operated as a family-owned business for over 20 years and are incredibly proud of our continued dedication to putting patients first and providing exceptional service to all our stakeholder partners. We’re excited to partner with Heritage Group in our next stage of growth and believe the firm’s unique capabilities and strategic relationships will help unlock tremendous potential for Nationwide.” 

Nationwide Medical’s product offering includes continuous positive airway pressure devices, oxygen therapy devices, non-invasive ventilators and continuous glucose monitors.   

Nashville, Tenn-based Heritage Group, whose limited partners include large provider systems, payers and health care service providers, says its investment in Nationwide Medical was the result of a targeted search for a platform in the HME industry. 

“As the market trend toward managing chronic conditions in the home accelerates, Nationwide’s differentiated clinical engagement model is set up to play a unique role in patients’ lives, and we look forward to being part of that journey,” said Jesse Bland, partner at Heritage Group. 

TripleTree served as exclusive financial advisor to Nationwide in connection with the transaction, and Leerink Partners served as exclusive financial advisor to Heritage Group. 

Insulet awarded $452M in intellectual property damages 

ACTON, Mass. – Insulet Corp., manufacturer of the tubeless Omnipod Insulin Management System, has been awarded $452 million in damages after it successfully defended its intellectual property against EOFlow Co. The jury found that EOFlow and several other defendants misappropriated Insulet’s trade secrets, awarding Insulet $170 million in compensatory damages and $282 million in exemplary damages for willful and malicious misappropriation for a total award of $452 million. "We are extremely pleased with the jury’s verdict, which validates our commitment to protecting our technology and defending our intellectual property against misappropriation and infringement," said Jim Hollingshead, Insulet’s president and CEO. "We will not only enforce our patents but also zealously protect our valuable trade secrets, in which we’ve invested heavily to improve the lives of people with diabetes." The trial was held in the U.S. District Court for the District of Massachusetts. Insulet announced in November that the Omnipod now integrates that Abbott’s FreeStyle Libre 2 Plus continuous glucose monitoring sensor in the U.S. 

Eastern MedTech adds contracting executive 

BOSTON – Eastern MedTech, a provider of continuous glucose monitoring and maternity supplies, has appointed Heather Davis as vice president of national value-based care contracting. “Eastern MedTech believes that value-based care is essential to addressing the health care cost crisis,” said Peter Falkson, CEO/founder at Eastern MedTech. “By aligning incentives between providers and health plans, value-based care models encourage collaboration and innovation to deliver high-quality, cost-effective care. Heather’s expertise will be invaluable as we continue to partner with health plans to improve patient outcomes and reduce costs.” Davis, a seasoned DME executive with 19 years of experience, brings a unique perspective to Eastern MedTech, having held leadership roles at both DME companies and health plans, and has a deep knowledge of alternative payment models. Eastern MedTech is now serving patients in more than 30 states. 

Tandem Diabetes receives Health Canada approval 

MARKHAM, Ontario – Tandem Diabetes Care has received authorization of sale by Health Canada, paving the way for in-warranty t:slim X2 insulin pump users to be full compatibility with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring Systems. The t:slim X2 insulin pump is the first and only insulin pump in Canada that is integrated with both Dexcom G6 and Dexcom G7. “Through our continued partnership with Tandem, we have seen the proven benefits of automated insulin delivery,” said André Côté, executive vice president and general manager of Dexcom Canada. “We’re proud that people living in Canada can now access the latest AID offering with Dexcom G7, our smallest and most accurate CGM.” In December 2023, the t:slim X2 pump with Dexcom G7 integration launched in the U.S., marking the first time an AID option was compatible with Dexcom’s latest CGM technology. Now, t:slim X2 users in Canada can experience even more choice when it comes to CGM compatibility, along with the option to spend more time in closed loop with Dexcom G7’s 30-minute sensor warm-up time. In addition, t:slim X2 users who pair Dexcom G7 with an Apple smartwatch can see their glucose numbers directly from their watch without having to access their pump or smartphone. 

HME Home Health expands reach 

RICHMOND, B.C. – HME Home Health has launched a commercial division to serve hospitals and long-term care facilities. “HME has long been a leader in the home health market and has well established relationships for rehab products with hospitals and long-term care sites,” said Robert Boscacci, CEO & co-founder. “With the launch of our new division, HME will now leverage our commercially licensed team by further expanding into accessibility and medical products in hospitals, long-term care and other facilities. HME Home Health has nine locations and more than 80,000 square feet of office and warehouse space in Richmond, Victoria, Surrey, Nanaimo, North Vancouver, Kelowna and Sechelt. The company's workforce is comprised of more than 130 highly-trained professionals, technicians and support staff.  In September, HME Home Health was named to The Globe and Mail’s Canada’s Top Growing Companies list for the third year in a row. The company ranked No. 376 out of 416 on three-year revenue growth of 75%. 

Dynamic Infusion solidifies presence in Atlantic 

DALLAS – Dynamic Infusion has acquired CCE Partners, d/b/a Solution Nursing, with operations in Maryland, Delaware, Pennsylvania and Northern Virginia, solidifying its presence in the Atlantic region. On a consolidated basis, Dynamic now visits patients in their homes more than 25,000 times a year across 14 states on behalf of more than 60 specialty pharmacies – with plans to expand further. "Solution brings more than 30 years of experience in the home infusion therapy industry," said Peter Harris, CEO & president of Dynamic. "Their expert nurses are well trained in managing high-tech infusion and injectable medications, ensuring patients receive safe, effective treatment in the comfort of their homes. This commitment to clinical excellence aligns perfectly with Dynamic's mission to deliver positive patient experiences and outcomes." Christina Sabin-Scharff and Charles Sperling, co-owners of Solution, will both continue to work with Dynamic and will be leading operations in the region. "We are excited to join the growing Dynamic Infusion team and look forward to combining our operations,” said Sabin-Scharff. “Partnering with Dynamic will allow us to extend our reach and continue to provide high quality patient care.” 

Guthrie tapped to chair Energy and Commerce 

WASHINGTON – Rep. Brett Guthrie, R-Ky., has been recommended by the House Republican Steering Committee to be the next chairman of the Energy And Commerce Committee, which has jurisdiction over a broad range of policy issues and federal departments, including health care, the Department Of Energy, the Food And Drug Administration and more, VGM Government Relations has reported. Guthrie has sat on five of the panel’s six subcommittees and is chair of its health subcommittee.  “Rep. Guthrie has long been receptive and supportive of a range of DMEPOS issues,” said Adam Miller, vice president of government relations at VGM. “His appointment as the next chairman of the Energy and Commerce Committee represents a unique opportunity for providers and stakeholders to work with a champion in Rep. Guthrie and his staff in the upcoming Congress. We have met with Rep. Guthrie and his staff on several occasions and will continue to meet with his office to further legislation that positively impacts providers.” Earlier this year, King Drug in Hartford, Ky., hosted a meet-and-greet event with Guthrie.